Directors

Tom began his working life in financial services in New York, specialising in European and Latin American debt. In 1983 he entered politics, and served for 14 years as Conservative MP for the Lancashire constituency of Bolton West.

During this period he founded the All Party Committee on Drug Misuse, and served as Parliamentary Private Secretary to the ministers in the Department of Health and Social Security and the Northern Ireland Office.

He was later appointed Government Whip, and served as a minister at the Department of Health and subsequently at the Home Office. Since 1998 Tom has been Chief Executive of the International Federation of Health Plans, the leading global network of the health insurance industry. He is founder and chairman of a family support charity, and advisor to an NHS Treatment Centre and a leading healthcare IT provider.

Stefano started his career with his family’s group of companies, which includes private clinics and diagnostic equipment manufacturing in Italy, France and the United States.

He joined Arthur Andersen in London in 1996, where he was a member of the healthcare corporate finance team. In 1999, Stefano founded NephroNet, a chain of independent dialysis centers in Italy, which was sold to Baxter in 2001. From 2001 to 2003 Stefano was a Managing Director of Baxter Renal Therapy Services. Since 2002 Stefano is a partner at Healthcare Capital Partners (London), a private equity and corporate finance advisory boutique specialized in life sciences and healthcare ventures that he founded. As part of his investment activities Stefano is a shareholder and board member of several healthcare ventures and private equity funds.

Stefano earned an MBA from the Imperial College Management School in 1994.

Scott started his career in banking with Merrill Lynch in New York in 1987. Formerly Scott was a senior manager in global corporate development at National Medical Care (NMC), at the time the world’s largest Haemdialysis provider. During his tenure at NMC he assisted in building the international division and completed over 100 haemodialysis clinic transactions.

He played a key role in building NMCs leading UK and European presence. Since 2002 Scott has been a partner at Healthcare Capital Partners, a company that he founded with Stefano Ciampolini. He is also CEO of Lipoxen Plc, a biotechnology company he listed on AIM (ticker symbol LPX) in 2006. Prior to HCP Scott was director (1996-2001) of Arthur Andersen’s Healthcare Corporate Finance, a practice he co-founded in 1996. While at Andersen, Scott advised a number of leading dialysis companies including Althin Medical (manufacturer of dialysis products and consumables) on the sale to Baxter (1999) and Total Renal Care (now DaVita) on their European business development initiatives (1997-1999).

Scott earned an MBA from the Babson Graduate School in 1993.

John Sergides holds a Masters in Mechanical Engineering from Imperial College London, but has spent most of his career working in the financial sector.

He is currently Head of Business Development and Strategy (Europe, Middle East and Africa) for Deutsche Bank Alternative Fund Services, Deutsche Bank, London, having previously worked as an Executive Director for Hedge Fund Services at JP Morgan in London and as a senior trader for the HSBC Group and for Barclays Capital in both London and Tokyo.

He is a Non-Executive Director of Point Nine Financial Group, a leader in the credit derivatives services industry, where he previously held the role of CEO.